RESPONSE TO SYMPTOMATIC TREATMENT IN MITRAL VALVE PROLAPSE, AN EXPERIENCE AT KHYBER PAKHTOONKHWA

Objectives: To determine the subjective response to treatment in mitral valve prolapse patients.Materials and Methods: This was a cross-sectional observational study conducted department of Cardiology LRH Peshawar, from 21 November 2019 30 April 2020. All consecutive patients having Prolapse fulfi lling inclusion criteria were studied. Their Statistical Analysis done with SPSS version 18.0 software. Percentages & Frequency used for categorical variables like ender, regurgitation treatment. While mean standard deviation quantitative age calculated.Results: A total No 142 have documented evidence echocardiographic included. They all treated Beta blockers selective serotonin reuptake inhibitors (SSRI). Mean 19.45±7.32 years. Females 89(62.7%). Out population 128(90%) palpitation, 111(78%) chest pain, 102(72%) dizziness, 93(65%) Apprehension Pre-syncope 85(60%). Of total, 32(22.53%) also taking ACI/ARB 42(29.5%) on benzodiazepine. 04 month’s documented. 16 lost follow up. In remaining 126 patients, medications excellent 21(16.67%), good 29(23.01%), satisfactory/Fair 41(32.53%). symptoms 23(18.25%) 12(9.5%) worsening symptoms.Conclusion: Symptomatic Mitral fairly respond SSRIs beta blockers.